HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Astragaloside IV-targeting miRNA-1 attenuates lipopolysaccharide-induced cardiac dysfunction in rats through inhibition of apoptosis and autophagy.

Abstract
Astragaloside IV (AS-IV), the major active constituent purified from Astragalus membranaceus, was previously reported to have protective effects against cardiac dysfunction. However, the underlying mechanism remains unknown. In the present study, we investigated the protective effect of AS-IV on lipopolysaccharide (LPS)-induced cardiac dysfunction and explored the potential mechanism by focusing on miRNA-1 (miR-1) at the animal and cellular levels. A series of methods were used, including echocardiography, flow cytometry, ELISA, immunofluorescence, transmission electron microscopy, RT-PCR, and western blotting. The results showed that both AS-IV and the miR-1 inhibitor improved cardiac dysfunction, reduced heart injury, inhibited apoptosis and autophagy, and regulated the expression of calcium- and mitochondrial energy metabolism-related proteins in the heart tissue of rats treated with LPS. Importantly, AS-IV downregulated the expression of miR-1 mRNA in heart tissue. All effects of AS-IV were at least partly abolished by miR-1 mimics. In the in vitro study, both AS-IV and the miR-1 inhibitor inhibited apoptosis and autophagy and regulated the expression of calcium- and mitochondrial energy metabolism-related proteins in heart cells treated with LPS. Similarly, AS-IV downregulated the expression of miR-1 mRNA in heart cells. All effects of AS-IV on cells were at least partly abolished by miR-1 mimics. Furthermore, miR-1 mimics exhibited effects similar to LPS both in animal and cellular studies. Taken together, these results suggest that AS-IV protects against LPS-induced cardiac dysfunction by inhibiting calcium-mediated apoptosis and autophagy by targeting miR-1, highlighting a new mechanism for the therapeutic effect of AS-IV on cardiac dysfunction.
AuthorsQiuning Wang, Xuefeng Yang, Ying Song, Xiaowei Sun, Wentao Li, Ling Zhang, Xueling Hu, Hong Wang, Nan Zhao, Ruming Zhuang, Xinling Xie, Futian Tang, Hongxin Wang
JournalLife sciences (Life Sci) Vol. 275 Pg. 119414 (Jun 15 2021) ISSN: 1879-0631 [Electronic] Netherlands
PMID33774032 (Publication Type: Journal Article)
CopyrightCopyright © 2021. Published by Elsevier Inc.
Chemical References
  • Cardiotonic Agents
  • Lipopolysaccharides
  • MIRN1 microRNA, rat
  • MicroRNAs
  • Saponins
  • Triterpenes
  • astragaloside A
Topics
  • Animals
  • Apoptosis (drug effects)
  • Autophagy (drug effects)
  • Cardiotonic Agents (pharmacology)
  • Echocardiography
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Fluorescent Antibody Technique
  • Heart (drug effects)
  • Heart Diseases (chemically induced, prevention & control)
  • Lipopolysaccharides (adverse effects)
  • Male
  • MicroRNAs (metabolism)
  • Microscopy, Electron, Transmission
  • Myocardium (metabolism, ultrastructure)
  • Rats
  • Rats, Sprague-Dawley
  • Saponins (pharmacology)
  • Triterpenes (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: